000 01407 a2200433 4500
005 20250516014909.0
264 0 _c20110712
008 201107s 0 0 eng d
022 _a1432-1238
024 7 _a10.1007/s00134-010-2087-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoyakkers, Annick A N M
245 0 0 _aSerum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.
_h[electronic resource]
260 _bIntensive care medicine
_cMar 2011
300 _a493-501 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study
650 0 4 _aAcute Kidney Injury
_xblood
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers
_xblood
650 0 4 _aCohort Studies
650 0 4 _aCystatin C
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeeds Assessment
650 0 4 _aRenal Replacement Therapy
700 1 _aKorevaar, Johanna C
700 1 _avan Suijlen, Jeroen D E
700 1 _aHofstra, Lieuwe S
700 1 _aKuiper, Michael A
700 1 _aSpronk, Peter E
700 1 _aSchultz, Marcus J
700 1 _aBouman, Catherine S C
773 0 _tIntensive care medicine
_gvol. 37
_gno. 3
_gp. 493-501
856 4 0 _uhttps://doi.org/10.1007/s00134-010-2087-y
_zAvailable from publisher's website
999 _c20443421
_d20443421